Tumour Registry Breast Cancer

The registry aims to collect and analyse information on the antineoplastic treatment of breast cancer in daily routine practice of office-based and clinic-based medical oncologists in Germany.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Breast Cancer Behavior Breast Diseases Breast Neoplasms Motor Activity Neoplasms Neoplasms by Site Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

About this study

The TMK is a prospective, longitudinal, nation wide cohort study with the purpose to record information on the antineoplastic treatment of breast cancer in Germany. The registry will follow patients for up to five years. It will identify common therapeutic sequences and changes in the treatment of the disease. At inclusion, data in patient characteristics, comorbidities, tumor characteristics, biomarker testing and previous treatments are collected. During the course of observation data on all systemic treatments, radiotherapies, surgeries, and outcome are documented.

The impact of nutrition (MaNut) and physical activity (MaNut) on the course of the adjuvant disease will be examined, as well as long-term effects of adjuvant treatment (MaTox) and the multiple patient-reported outcomes (MaLife).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Breast cancer
18 years and older
Antineoplastic or antihormonal treatment

Exclusion criteria

No breast cancer
Below 18 years
No antineoplastic or antihormonal treatment

Treatment and study plan

Primary outcomes

Course of Antineoplastic Treatment

Time frame: 5 years

Sponsors and collaborators

Lead sponsor

iOMEDICO AG

Industry

Collaborators

Arbeitsgemeinschaft fur Internistische Onkologie
Arbeitskreis Klinische Studien

Registry information

Official study title

Clinical Registry to Present Treatment and Sequences of Treatments in Routine Practice in Germany

Acronym: TMK

Important dates

Study start: 2007
Primary completion: 2021
Study completion: 2021
First posted: May 11, 2011
Registry last updated: Aug 28, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed